Image

Implementation of Glucose Management Software (EndoTool) Intra-Operatively in Cardiac Surgery Patients to Improve Post-Operative Blood Glucose Control and Compliance with SCIP INF-4

Objective

This retrospective study compares SCIP-Inf-4 compliance with use of EndoTool solely for post-operative glucose management to SCIP-Inf-4 compliance with use of EndoTool for both intra- and post-operative glucose management.

Setting

1,018-bed academic medical center and Level 1 trauma center.

Results
  • Percentage of patients in full SCIP-Inf-4 compliance increased from 80.5% to 89.4% with use of EndoTool for both intra- and post-operative glucose management.
  • Percentage of patients in SCIP-Inf-4 compliance post-operative Day 1 increased from 91.7% to 98.5% with use of EndoTool for both intra- and post-operative glucose management.
  • Among patients in SCIP-Inf-4 compliance post-operative Day 1 but not post-operative Day 2, all (100%) had been discontinued from EndoTool prior to the 6:00 am blood glucose check.
Conclusions

Use of EndoTool for both intra- and post-operative glucose management of cardiac surgery patients leads to improved SCIP-Inf-4 compliance (a program that aims to decrease incidence of surgical site infections) over use of EndoTool solely for post-operative glucose management; however, early discontinuation of patients from EndoTool prior to the post-operative Day 2 6:00 am blood glucose check has a negative effect on SCIP-Inf-4 compliance.

Authors

Michael Denaburg, PharmD; Earnest Alexander, PharmD, FCCM; Maresa Glass, PharmD, BCPS; Ren Chen, MD, MPH.

Source

Presented at Society of Critical Care Medicine Critical Care Congress. Published in Critical Care Medicine, Volume 40, Issue 12, p1-328.

Year

2013